Health
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store – Yahoo News Australia
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from…
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full-strength doses were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full-strength dose to follow — that one was 90% effective.
Oxford’s results may not have…
-
General13 hours agoClean-up underway after stormy weather hits, 400 calls for help in Sydney
-
General24 hours agoMan who shot poodle in Central Coast caravan park robbery sentenced to eight years in prison
-
Noosa News15 hours agoFeral pigs devour 99 out of every 100 lambs on this Central West NSW farm
-
Noosa News23 hours agoAerosol physicist Lidia Morawska wins 2025 Prime Minister’s Prize for Science